Sign In

Eleonora Cavani

Founder and CEO at Alba Health

Eleonora Cavani is a seasoned professional with a focus on combating chronic diseases since childhood at Alba Health, utilizing cutting-edge microbiome science and the world's largest database.

With over 10 years of experience at the nexus of science, data, and business, Eleonora has led impactful projects, including developing a machine learning model for COVID-19 advising Fortune 500 companies in collaboration with Stanford.

Her expertise spans from spearheading stability studies model at Ferring Pharmaceuticals, designing and testing digital health products at LEO Pharma, to creating various enduring products like human skin explant model and brain physical model.

Eleonora pursued her education extensively, from completing the MIT - Harvard Medical School Healthcare Innovation Bootcamp to earning a Master's Degree in Pharmaceutical Design and Engineering at DTU - Technical University of Denmark.

Her academic journey also includes studies in International Business at The Chinese University of Hong Kong, Biotechnology at Università degli Studi di Modena e Reggio Emilia, and an exchange program in Biotechnology at Universitat Autònoma de Barcelona.

Previously, Eleonora held key roles such as Founder and CEO at Alba Health, Project Leader at Boston Consulting Group (BCG), Consultant at BCG, and strategic positions at Ferring Pharmaceuticals, LEO Pharma, Rensselaer Polytechnic Institute, BluSense Diagnostics ApS, and Universitat Autonoma de Barcelona.

Highlights

Jun 21 · linkedin

I'm beyond excited to announce Alba Health's $2m pre-seed round on Forbes, to advance our mission to empower families in achieving a healthy lifestyle, while collecting anonymized data to advance chronic disease prevention.

I have several allergies and eczema and I've been wondering for years whether we will be able to cure them or prevent them for good. Not only allergies - also other chronic conditions (asthma, auto-immune conditions, obesity, diabetes), which now affect 40% of children in the US and are expected to cost over $47 trillion in 2030 by the World Economic Forum.

Last year, I teamed up with Prof. Willem M. De Vos to start Alba Health, driven by the insight that gut health in the first years of life is linked to common child symptoms such as colic and sleep disruption, as well as chronic conditions in later life like allergies, asthma, obesity, and diabetes.

I couldn't be more excited to work on this mission with Willem, our phenomenal team and group of investors and partners! Exciting times ahead!

Read the article on Forbes below Read about us here: www.albahealth.co Join the team: www.albahealth.co/about-us

A big THANK YOU to our investors and early supporters Voima Ventures, Noaber, Octopus Ventures, Bust, Joyance Partners, Petteri Lahtela, Henriette Schultz Kirkegaard, Victor Henning, Viktor Lundberg, Stine Marie Skov Jørgensen, Thor Skov Jørgensen, Benjamin Siranosian, Riccardo Pozzoli, Enrico Pandian, Alice Ravizza, Ehrenstråhle & Wågnert as well as BioInnovation Institute for early support through Venture Lab, our stellar team Willem M. De Vos, Marcela Pereira, Alessio Sportelli, Adelina Vikström, Hamza Hayat and the wonderful Marija Butkovic for featuring us!

Eleonora Cavani
Add to my network

Location

Stockholm, Stockholm County, Sweden